Suspected NAFLD patients
NASH + NAS≥4 + F≥2
Screening for clinical trial and identifying at-risk NASH patients
FibroScan® results (LSM by VCTE™ & CAP™) + laboratory parameter (AST)
Enhancing FibroScan® liver disease assessment with biological markers
A single biomarker cannot answer to all questions.
With FibroScan®-based scores, you can combine FibroScan® results with other parameters to get the best performance and a better identification of your patients.
Scores by echosens are available on myFibroScan application.
The non-invasive gold standard solution for comprehensive management of liver health
Choose the right probe for the right patient type
Optimize clinical workflows with real-time secure data transmission
Scores by echosens are defined by regulations